Skip to main content

Scripps Team Shows Potential of microRNA Knockdown for Ocular Diseases


Investigators from the Scripps Research Institute have published new preclinical data indicating that inhibiting microRNA-132 in the eye can prevent the neovascularization associated with wet age-related macular degeneration and similar eye conditions.

In the study, which appears in the Journal of Clinical Investigation, Scripps scientists led by Martin Friedlander found that the Ras pathway, which functions downstream of a number of cytokines including the angiogenic protein vascular endothelial growth factor, is "active in the growing vascular front of developing and pathological vascular networks."

They also observed that the endogenous Ras inhibitor p120RasGAP is downregulated in mouse models of pathological ocular angiogenesis.

Building off of data published last year by a University of California, San Diego group that show miR-132 acts as an "angiogenic switch" by targeting p120RasGAP in the endothelium and inducing neovascularization, the Scripps researchers demonstrated that blocking expression of the miRNA boosted p120RasGAP levels. In doing so, the anti-miRNA treatment promoted quiescence and prevented neovascularization, they wrote in JCI.

“We believe that targeting and inhibiting the action of microRNAs involved could represent a novel and effective way to treat a broad range of neovascular eye diseases such as diabetic retinopathy, macular degeneration, and macular telangiectasia," Friedlander said in a statement.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.